Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review

Harold Edward Bays
{"title":"Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review","authors":"Harold Edward Bays","doi":"10.1016/j.obpill.2023.100076","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>A common adiposopathic complication of obesity is type 2 diabetes mellitus. Healthful weight reduction in patients with obesity can improve glucose metabolism and potentially promote remission of type 2 diabetes mellitus. However, weight-reduction in patients with increased adiposity is impaired among patients with type 2 diabetes mellitus compared to patients without diabetes mellitus.</p></div><div><h3>Methods</h3><p>Data for this review were derived from PubMed and applicable websites.</p></div><div><h3>Results</h3><p>Among patients with increased body fat, the mechanisms underlying impaired weight reduction for those with type 2 diabetes mellitus are multifactorial, and include energy conservation (i.e., improved glucose control and reduced glucosuria), hyperinsulinemia (commonly found in many patients with type 2 diabetes mellitus), potential use of obesogenic anti-diabetes medications, and contributions from multiple body systems. Other factors include increased age, sex, genetic/epigenetic predisposition, and obesogenic environments.</p></div><div><h3>Conclusions</h3><p>Even though type 2 diabetes mellitus impairs weight reduction among patients with increased adiposity, clinically meaningful weight reduction improves glucose metabolism and can sometimes promote diabetes remission. An illustrative approach to mitigate impaired weight reduction due to type 2 diabetes mellitus is choosing anti-diabetes medications that increase insulin sensitivity and promote weight loss and deprioritize use of anti-diabetes medications that increase insulin exposure and promote weight gain.</p></div>","PeriodicalId":100977,"journal":{"name":"Obesity Pillars","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Pillars","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667368123000220","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background

A common adiposopathic complication of obesity is type 2 diabetes mellitus. Healthful weight reduction in patients with obesity can improve glucose metabolism and potentially promote remission of type 2 diabetes mellitus. However, weight-reduction in patients with increased adiposity is impaired among patients with type 2 diabetes mellitus compared to patients without diabetes mellitus.

Methods

Data for this review were derived from PubMed and applicable websites.

Results

Among patients with increased body fat, the mechanisms underlying impaired weight reduction for those with type 2 diabetes mellitus are multifactorial, and include energy conservation (i.e., improved glucose control and reduced glucosuria), hyperinsulinemia (commonly found in many patients with type 2 diabetes mellitus), potential use of obesogenic anti-diabetes medications, and contributions from multiple body systems. Other factors include increased age, sex, genetic/epigenetic predisposition, and obesogenic environments.

Conclusions

Even though type 2 diabetes mellitus impairs weight reduction among patients with increased adiposity, clinically meaningful weight reduction improves glucose metabolism and can sometimes promote diabetes remission. An illustrative approach to mitigate impaired weight reduction due to type 2 diabetes mellitus is choosing anti-diabetes medications that increase insulin sensitivity and promote weight loss and deprioritize use of anti-diabetes medications that increase insulin exposure and promote weight gain.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
为什么2型糖尿病会损害肥胖患者的体重减轻?回顾
肥胖的常见脂肪病并发症是2型糖尿病。肥胖患者健康减肥可以改善葡萄糖代谢,并有可能促进2型糖尿病的缓解。然而,与没有糖尿病的患者相比,2型糖尿病患者中肥胖增加的患者的体重减轻受到损害。方法本综述的数据来源于PubMed和相关网站。结果在体脂增加的患者中,2型糖尿病患者体重减轻受损的机制是多因素的,包括节能(即改善血糖控制和减少血糖)、高胰岛素血症(常见于许多2型糖尿病病人)、潜在的肥胖抗糖尿病药物的使用,以及来自多个身体系统的贡献。其他因素包括年龄、性别、遗传/表观遗传易感性和肥胖环境的增加。结论尽管2型糖尿病阻碍了肥胖增加患者的减肥,但有临床意义的减肥可以改善糖代谢,有时还可以促进糖尿病的缓解。减轻2型糖尿病导致的体重减轻障碍的一种说明性方法是选择增加胰岛素敏感性和促进体重减轻的抗糖尿病药物,并优先使用增加胰岛素暴露和促进体重增加的抗糖尿病药。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Efficacy of in-person versus digital enhanced lifestyle interventions in adults with overweight and obesity Effect of resveratrol supplementation on metabolic risk markers and anthropometric parameters in individuals with obesity or overweight: A systematic review and meta-analysis of randomized controlled trials Diagnosis and management of metabolic dysfunction- associated steatotic liver disease in South Asians- A clinical review Case report of a female western Indian vegetarian with obesity Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1